Skip to main content
Equibles

Focus Partners Wealth

Position in CRDF — Cardiff Oncology, Inc.

CIK 1542153 ST LOUIS, MO
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$13,187
+$2,506 QoQ
Shares Held
10,144
+95.6% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 104 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Focus Partners Wealth holds $223,178,682 across 77 Biotechnology names. CRDF ranks #77 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 128,958 $64,057,307
2 CELC
Celcuity Inc.
 232,559 $24,330,322
3 ABVX
Abivax S.A.
 161,874 $21,571,329
4 INCY
Incyte Corp
 161,917 $18,354,911
5 HALO
Halozyme Therapeutics, Inc.
 163,036 $12,760,827
6 IONS
Ionis Pharmaceuticals Inc
 147,917 $11,728,338
7 REGN
Regeneron Pharmaceuticals, Inc.
 14,043 $8,756,372
8 EXEL
Exelixis, Inc.
 112,673 $6,130,537

All Filings in CRDF

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,187 10,144
2025-09-30 $10,681 5,185